Literature DB >> 11042188

The potency and specificity of the interaction between the IA3 inhibitor and its target aspartic proteinase from Saccharomyces cerevisiae.

L H Phylip1, W E Lees, B G Brownsey, D Bur, B M Dunn, J R Winther, A Gustchina, M Li, T Copeland, A Wlodawer, J Kay.   

Abstract

The yeast IA3 polypeptide consists of only 68 residues, and the free inhibitor has little intrinsic secondary structure. IA3 showed subnanomolar potency toward its target, proteinase A from Saccharomyces cerevisiae, and did not inhibit any of a large number of aspartic proteinases with similar sequences/structures from a wide variety of other species. Systematic truncation and mutagenesis of the IA3 polypeptide revealed that the inhibitory activity is located in the N-terminal half of the sequence. Crystal structures of different forms of IA3 complexed with proteinase A showed that residues in the N-terminal half of the IA3 sequence became ordered and formed an almost perfect alpha-helix in the active site of the enzyme. This potent, specific interaction was directed primarily by hydrophobic interactions made by three key features in the inhibitory sequence. Whereas IA3 was cut as a substrate by the nontarget aspartic proteinases, it was not cleaved by proteinase A. The random coil IA3 polypeptide escapes cleavage by being stabilized in a helical conformation upon interaction with the active site of proteinase A. This results, paradoxically, in potent selective inhibition of the target enzyme.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11042188     DOI: 10.1074/jbc.M008520200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

Review 1.  Evolutionary families of peptidase inhibitors.

Authors:  Neil D Rawlings; Dominic P Tolle; Alan J Barrett
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

2.  Continuous wave W- and D-band EPR spectroscopy offer "sweet-spots" for characterizing conformational changes and dynamics in intrinsically disordered proteins.

Authors:  Thomas M Casey; Zhanglong Liu; Jackie M Esquiaqui; Natasha L Pirman; Eugene Milshteyn; Gail E Fanucci
Journal:  Biochem Biophys Res Commun       Date:  2014-06-17       Impact factor: 3.575

3.  Analysis of binding interactions of pepsin inhibitor-3 to mammalian and malarial aspartic proteases.

Authors:  Rebecca E Moose; José C Clemente; Larry R Jackson; Minh Ngo; Kimberly Wooten; Richard Chang; Antonette Bennett; Sibani Chakraborty; Charles A Yowell; John B Dame; Mavis Agbandje-McKenna; Ben M Dunn
Journal:  Biochemistry       Date:  2007-11-16       Impact factor: 3.162

4.  Multi-scaled explorations of binding-induced folding of intrinsically disordered protein inhibitor IA3 to its target enzyme.

Authors:  Jin Wang; Yong Wang; Xiakun Chu; Stephen J Hagen; Wei Han; Erkang Wang
Journal:  PLoS Comput Biol       Date:  2011-04-07       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.